Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in European Caucasians

Journal of Rheumatology

Volumn 36, Issue 2, 2009, Pages 337-340

  Wipff, Julien ^a,b   Gallier, Guillaume ^a,b   Dieude, Philippe ^a   Avouac, Jerome ^a,b   Tiev, Kiet ^c   Hachulla, Eric ^d   Granel, Brigitte ^e   Diot, Elisabeth ^f   Sibilia, Jean ^g   Mouthon, Luc ^a   Meyer, Olivier ^a   Kahan, Andre ^a   Varret, Mathilde ^b   Boileau, Catherine ^b,h   Allanore, Yannick ^a,b,i  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIV LILLE   (France)

^e Aix Marseille university   (France)

^f CHU BRETONNEAU   (France)

^g UNIVERSITÉ DE STRASBOURG   (France)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

ⁱ A Paré Hospital ^*  (France)

Author keywords

Angiotensin converting enzyme; Polymorphism; Systemic sclerosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; ALLELE; ARTICLE; BLOOD VESSEL INJURY; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; SKIN ULCER; SYSTEMIC SCLEROSIS; VASCULAR DISEASE; AGED; COMORBIDITY; ENZYMOLOGY; ETHNOLOGY; EUROPE; FRANCE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE;

ADULT; AGED; CASE-CONTROL STUDIES; COMORBIDITY; DNA MUTATIONAL ANALYSIS; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; KIDNEY DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RENIN; SCLERODERMA, SYSTEMIC;

EID: 64849084206     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080622     Document Type: Article

References (15)

1. Kincaid-Smith P. Renal pathology in hypertension and the effects of treatment. Br J Clin Pharmacol 1982;13:107-115 (Pubitemid 13139918)
2. Steen VD, Constantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990;113:352-357 (Pubitemid 20262820)
3. Szucs G, Timar O, Szekanecz Z, et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis. Relevance for prevention of vascular complications. Rheumatology Oxford 2007;46:759-762
4. Bartoli F, Angotti C, Fatini C, et al. Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology Oxford 2007;46:772-775 (Pubitemid 47061706)
5. Allanore Y, Wipff J, Kahan A, Boileau C. Genetic basis for systemic sclerosis. Joint Bone Spine 2007;74:577-583 (Pubitemid 350245624)
6. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion 7 deletion polymorphism of the human angiotensin converting enzyme gene (DCP1). Nucleic Acids Res 1992;20:1433-1437
7. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205 (Pubitemid 18073738)
8. Dieude P, Guedj M, Wipff J, et al. The PTPN22 620W allele confers susceptibility to systemic sclerosis: a large case control study among European Caucasians and meta-analysis. Arthritis Rheum 2008;58:2183-2188
9. Fatini C, Gensini F, Sticchi E, et al. High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med 2002;112:540-544 (Pubitemid 34518313)
10. Assassi S, Mayes MD, McNearney T, et al. Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis. Am J Med 2005;118:907-911 (Pubitemid 41097470)
11. Guiducci S, Fatini C, Georgountzos A, et al. Etrurians vs Greeks: May ACE I/D polymorphism still be considered as a marker of susceptibility to SSc? Clin Exp Rheumatol 2006;24:432-434
12. Allanore Y, Avouac J, Wipff J, Kahan A. New therapeutic strategies in the management of systemic sclerosis. Exp Opin Pharmacotherapy 2007;8:607-615 (Pubitemid 46547014)
13. Joung CI, Park YW, Kim SK, Uhm WS, Kim TH, Yoo DH. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Korean patients with systemic sclerosis. J Korean Med Sci 2006;21:329-332
14. Li R, Nicklas B, Pahor M, et al. Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study. J Hum Hypertens 2007;21:673-682 (Pubitemid 47162730)
15. Allanore Y, Seror R, Chevrot A, Kahan A, Drapé JL. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis. Arthritis Rheum 2007;56:2747-2754 (Pubitemid 47237294)